Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Gynecologic Oncology Group

Known as: GOG 
A non-profit NCI-supported organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific… Expand
National Institutes of Health

Related topics

Related topics

1 relation
GOG

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study.
PURPOSE The study's objective was to compare the quality of life (QoL) of patients with endometrial cancer undergoing surgical… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Highly Cited
2003
Highly Cited
2003
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG‐Ntx) questionnaire for patients receiving systemic chemotherapy
The purpose of this study was to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Highly Cited
1999
Highly Cited
1999
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a…
PURPOSE In 1986, a protocol comparing primary radiation therapy (RT) plus hydroxyurea (HU) to irradiation plus fluorouracil (5-FU… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
1998
Highly Cited
1998
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
PURPOSE A multicenter trial of chemoradiation therapy to evaluate the feasibility of extended field radiation therapy (ERT) with… Expand
Highly Cited
1997
Highly Cited
1997
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
PURPOSE Cisplatin, mitolactol (dibromodulcitol), and ifosfamide have been the most active single agents in squamous carcinoma of… Expand
Highly Cited
1996
Highly Cited
1996
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
This is a Phase II groupwide study of the Gynecologic Oncology Group (GOG) to determine the toxicity and efficacy of a… Expand
Highly Cited
1994
Highly Cited
1994
Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
PURPOSE This Gynecologic Oncology Group (GOG) trial of paclitaxel (Taxol; Bristol-Myers Squibb Co, Princeton, NJ) as salvage… Expand
Highly Cited
1991
Highly Cited
1991
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
Long-term follow-up was obtained on 726 women with advanced ovarian carcinoma (suboptimal stage III and stage IV) who had… Expand
Highly Cited
1991
Highly Cited
1991
Carcinoma of the cervix treated with radiation therapy I. A multi‐variate analysis of prognostic variables in the gynecologic oncology group
Between 1977 and 1985, the Gynecologic Oncology Group (GOG) conducted three clinical trials in locally advanced carcinoma of the… Expand
Highly Cited
1980
Highly Cited
1980
Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group.
Abstract A multiinstitutional study by the Gynecologic Oncology Group (GOG) has confirmed that clinical staging often is… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE